Skip to main content
. 2022 Mar 2;62(3):807–817. doi: 10.47162/RJME.62.3.19

Table 2.

Comparison of clinical evolution prediction indicators in the two groups of patients

Study group

Indicator

 

Form of onset

Insidious

Reactive

M group, n (%)

34 (25.00%)

102 (75.00%)

P group, n (%)

43 (31.39%)

94 (68.61%)

Total, n (%)

77 (28.21%)

196 (71.79%)

 

No. of previous admissions

4

5

6

7+

M group, n (%)

58 (42.65%)

24 (17.65%)

21 (15.44%)

33 (24.26%)

P group, n (%)

58 (42.34%)

29 (21.17%)

20 (14.60%)

30 (21.90%)

Total, n (%)

116 (42.49%)

53 (19.41%)

41 (15.02%)

63 (23.08%)

 

Previous psychological trauma

Absent

Present

M group, n (%)

97 (71.32%)

39 (28.68%)

P group, n (%)

102 (74.45%)

35 (25.55%)

Total, n (%)

199 (72.89%)

74 (27.11%)

 

Psychiatric history

Absent

Present

M group, n (%)

105 (77.21%)

31 (22.79%)

P group, n (%)

111 (81.02%)

26 (18.98%)

Total, n (%)

216 (79.12%)

57 (20.88%)

 

Somatic comorbidities

Absent

Present

 

M group, n (%)

35 (25.74%)

101 (74.26%)

 

P group, n (%)

40 (29.20%)

97 (70.80%)

 

Total, n (%)

75 (27.47%)

198 (72.53%)

 

 

Suicidal behavior and ideation

 

Absent

Present

 

M group, n (%)

125 (91.91%)

11 (8.09%)

 

P group, n (%)

124 (90.51%)

13 (9.49%)

 

Total, n (%)

249 (91.21%)

24 (8.79%)

 

 

Smoking

 

No

Yes

 

M group, n (%)

104 (76.47%)

32 (23.53%)

 

P group, n (%)

114 (83.21%)

23 (16.79%)

 

Total, n (%)

218 (79.85%)

55 (20.15%)

 

 

Alcohol consumption

 

Abstinence / occasional

Moderate / abusive

 

M group, n (%)

68 (50.00%)

68 (50.00%)

 

P group, n (%)

74 (54.01%)

63 (45.99%)

 

Total, n (%)

142 (52.01%)

131 (47.99%)

 

M: Medication group; n: No. of cases; P: Psychotherapy and medication group